Industrial biotech firm Evolva now has the rights to use CRISPR/Cas9 to engineer yeast and fungi that make compounds like stevia and resveratrol.
The researchers reported correcting beta thalassemia in a mouse model via a gene editing method delivered by an intravenous injection.
A modified version of a commercially available magnetic bead cell sorting instrument from Miltenyi Biotec could be deployed to areas without cGMP facilities.
The IPO amount is about half of what the company's competitors, Editas Medicine and Intellia Therapeutics, raised in their own IPOs earlier this year.
The agency says the Safe Genes program will help provide the genome editing field with tools to safely pursue research and to get out in front of new threats.
Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.
In Nature this week: genetic history of HIV in the US, and more.
There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.
A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.